1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Asthma Drugs Market – By Medication

1.3.2        North America Asthma Drugs Market – By Route of Administration

1.3.3        North America Asthma Drugs Market – By Distribution Channel

1.3.4        North America Asthma Drugs Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Asthma Drugs Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        North America – PEST Analysis

4.3         Expert Opinion

5.           Asthma Drugs Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Growing Environmental Implications & Genetic Implications of Air Pollution

5.1.2        More Vulnerability in Specific Ethnic Groups

5.1.3        Growing Exposure to Coarse Particulate Matters

5.1.4        Growing Prevalence of Physiological Disorders Harboring Asthma

5.2         Market Restraints

5.2.1        Unmet Medical Needs

5.3         Market Opportunities

5.3.1        Opportunities with Commercialization of Biologics

5.4         Future Trends

5.4.1        Increasing Research Activities and Product Innovations

5.5         Impact Analysis

6.           Asthma Drugs Market– North America Analysis

6.1         North America Asthma Drugs Market Revenue Forecast and Analysis

7.           Asthma Drugs Market Analysis – by Medication

7.1         Overview

7.2         Asthma Drugs Market Revenue Share, by Medication (2021 and 2028)

7.3         Quick Relief Medications

7.3.1        Overview

7.3.2        Quick Relief Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Long-term Control Medications

7.4.1        Overview

7.4.2        Long-term Control Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)

8.           Asthma Drugs Market Analysis – By Route of Administration

8.1         Overview

8.2         Asthma Drugs Market Revenue Share, By Route of Administration (2021 and 2028)

8.3         Inhaled

8.3.1        Overview

8.3.2        Inhaled: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

8.4         Prefilled Syringe/Vials

8.4.1        Overview

8.4.2        Prefilled Syringe/Vials: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

8.5         Others (Oral, Nasal, Ophthalmic Etc.)

8.5.1        Overview

8.5.2        Others: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

9.           Asthma Drugs Market Analysis – By Distribution Channel

9.1         Overview

9.2         Asthma Drugs Market Revenue Share, By Distribution Channel (2021 and 2028)

9.3         Online Pharmacies

9.3.1        Overview

9.3.2        Online Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

9.4         Hospital Pharmacies

9.4.1        Overview

9.4.2        Hospital Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

9.5         Retail Pharmacies and Drugstores

9.5.1        Overview

9.5.2        Retail Pharmacies and Drugstores: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

10.        Asthma Drugs Market – North America Analysis

10.1      North America: Asthma Drugs Market Revenue and Forecast to 2028

10.1.1     Overview

10.1.2     North America: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.3     North America: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.1.4     North America: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.1.5     North America: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.6     North America: Asthma Drugs Market, by Country, 2021 & 2028 (%)

10.1.6.1       US: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.1.1       US: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.1.2       US: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.1.6.1.3       US: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.1.6.1.4       US: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.6.2       Canada: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.2.1       Canada: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.2.2       Canada: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.1.6.2.3       Canada: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.1.6.2.4       Canada: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.6.3       Mexico: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.3.1       Mexico: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.3.2       Mexico: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.1.6.3.3       Mexico: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.1.6.3.4       Mexico: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

11.        Asthma Drugs Market–Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      AstraZeneca

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      TEVA PHARMACEUTICAL INDUSTRIES LTD

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      GlaxoSmithKline plc.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Boehringer Ingelheim International GmbH

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Merck & Co., Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Koninklijke Philips N.V.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Sanofi

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Pfizer Inc. (Arena Pharmaceutical GmbH)

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Novartis AG

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Abbott

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             Odds Ratio (OR) For Mental Disorders among Adults with Asthma Vs Without Asthma

Table 2.             Asthma Death Rates for Select Countries, 2018

Table 3.             Common SABAs

Table 4.             Commonly inhaled corticosteroids

Table 5.             North America: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 6.             North America: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 7.             North America: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 8.             US: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 9.             US: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 10.          US: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 11.          Canada: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 12.          Canada: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 13.          Canada: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 14.          Mexico: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 15.          Mexico: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 16.          Mexico: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 17.          Organic Developments in the Asthma Drugs Market

Table 18.          Inorganic Developments in the Asthma Drugs Market

Table 19.          Glossary of Terms, Asthma Drugs Market

LIST OF FIGURES

Figure 1.           Asthma Drugs Market Segmentation

Figure 2.           Asthma Drugs Market, By Country

Figure 3.           Europe Asthma Drugs Market Overview

Figure 4.           The Long Term Control Medications Segment Held Largest Share of Mode of Service in the Asthma Drugs Market

Figure 6.           North America Asthma Drugs Market- Leading Country Markets (US$ Million)

Figure 7.           North America PEST Analysis

Figure 8.           Expert Opinion

Figure 9.           Impact of Low Mood/Anxiety on Asthma

Figure 10.        Asthma Drugs Market Impact Analysis of Drivers and Restraints

Figure 11.        North America Asthma Drugs Market– Revenue Forecast and Analysis – 2020- 2028

Figure 12.        Asthma Drugs Market Revenue Share, by Medication (2021 and 2028)

Figure 13.        Quick Relief Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Long-term Control Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Asthma Drugs Market Share, By Route of Administration, 2021 and 2028 (%)

Figure 16.        Inhaled: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 17.        Prefilled Syringe/Vials: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 18.        Others: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 19.        Asthma Drugs Market Share, By Distribution Channel, 2021 and 2028 (%)

Figure 20.        Online Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 21.        Hospital Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 22.        Retail Pharmacies and Drugstores: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 23.        North America: Asthma Drugs Market, by Key Country – Revenue (2021) (USD Million)

Figure 24.        North America: Asthma Drugs Market Revenue and Forecast to 2028 (USD Million)

Figure 25.        North America: Asthma Drugs Market, by Country, 2021 & 2028 (%)

Figure 26.        Prevalence of Asthma by Age, Sex, and Race/Ethnicity, 2019

Figure 27.        US: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

Figure 28.        Prevalence of Diagnosed Asthma Among Canadians (%), By Age Group and Sex, 2011-12

Figure 29.        Age-Standardized Prevalence of Diagnosed Asthma Among Canadians, by Sex and Year

Figure 30.        Canada: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

Figure 31.        Mexico: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)